- Home
- SSB vs VTRS Comparison
SSB vs VTRS Comparison
Compare SSB & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSB
- VTRS
- Stock Information
- Founded
- SSB 1933
- VTRS 1961
- Country
- SSB United States
- VTRS United States
- Employees
- SSB N/A
- VTRS N/A
- Industry
- SSB Major Banks
- VTRS Medicinal Chemicals and Botanical Products
- Sector
- SSB Finance
- VTRS Health Care
- Exchange
- SSB Nasdaq
- VTRS Nasdaq
- Market Cap
- SSB 10.0B
- VTRS 9.0B
- IPO Year
- SSB 1997
- VTRS N/A
- Fundamental
- Price
- SSB $84.82
- VTRS $7.56
- Analyst Decision
- SSB Strong Buy
- VTRS Hold
- Analyst Count
- SSB 10
- VTRS 4
- Target Price
- SSB $118.56
- VTRS $10.50
- AVG Volume (30 Days)
- SSB 924.2K
- VTRS 17.3M
- Earning Date
- SSB 04-24-2025
- VTRS 05-08-2025
- Dividend Yield
- SSB 2.54%
- VTRS 6.50%
- EPS Growth
- SSB 7.89
- VTRS N/A
- EPS
- SSB 6.97
- VTRS N/A
- Revenue
- SSB $1,701,741,000.00
- VTRS $14,739,300,000.00
- Revenue This Year
- SSB $52.14
- VTRS N/A
- Revenue Next Year
- SSB $8.19
- VTRS $1.20
- P/E Ratio
- SSB $12.17
- VTRS N/A
- Revenue Growth
- SSB 4.70
- VTRS N/A
- 52 Week Low
- SSB $70.68
- VTRS $6.85
- 52 Week High
- SSB $114.27
- VTRS $13.55
- Technical
- Relative Strength Index (RSI)
- SSB 42.74
- VTRS 34.97
- Support Level
- SSB $82.98
- VTRS $7.34
- Resistance Level
- SSB $85.36
- VTRS $7.70
- Average True Range (ATR)
- SSB 4.54
- VTRS 0.43
- MACD
- SSB 0.06
- VTRS 0.01
- Stochastic Oscillator
- SSB 41.52
- VTRS 36.41
About SSB SouthState Corporation
SouthState Corp is a United States-based bank holding company. It provides a wide range of banking services and products to its customers through a wholly-owned bank subsidiary, South State Bank. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time and savings deposits, lending and credit cards servicing, ATM processing, and wealth management and trust services.
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.